Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, binding its ligand (ICOS-L) on activated T cells. The structure of the ICOS/ICOS-L complex reveals a distinct receptor binding orientation. The structures of ICOS and ICOS-L in complex with potentially therapeutic antibodies...
Guardado en:
Autores principales: | Edurne Rujas, Hong Cui, Taylor Sicard, Anthony Semesi, Jean-Philippe Julien |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b38ff9a498494347a9468808e58367ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ICO AND STO AS MODERN TOOLS FOR CROWDFUNDING STARTUPS
por: A. V. Kozhanova
Publicado: (2020) -
Initial Coin Offerings (ICOs): benefits, risks and success measures
por: Alfreda Šapkauskienė, et al.
Publicado: (2020) -
LEGAL APPROACHES FOR THE REGULATION OF CRYPTOCURRENCY AND ICO IN FOREIGN COUNTRIES AND THE EUROPEAN UNION
por: N. Efimova
Publicado: (2018) -
Binding of NUFIP2 to Roquin promotes recognition and regulation of ICOS mRNA
por: Nina Rehage, et al.
Publicado: (2018) -
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
por: Dmitriy Zamarin, et al.
Publicado: (2017)